Analysen von Michael Leuchten
| 21.10.19 | Sartorius vz. Neutral | UBS AG | |
| 08.08.19 | Merck Neutral | UBS AG | |
| 25.07.19 | Roche Neutral | UBS AG | |
| 19.07.19 | Sartorius vz. Neutral | UBS AG | |
| 02.07.19 | Sartorius vz. Neutral | UBS AG | |
| 14.05.19 | Merck Neutral | UBS AG | |
| 13.05.19 | Merck Neutral | UBS AG | |
| 25.04.19 | Merck Neutral | UBS AG | |
|
Werbung
|
|||
| 24.04.19 | Novartis Neutral | UBS AG | |
| 18.04.19 | Sartorius vz. Neutral | UBS AG | |
| 17.04.19 | Roche Neutral | UBS AG | |
| 09.04.19 | Merck Neutral | UBS AG | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | Merck Neutral | UBS AG | |
| 15.03.19 | Merck Neutral | UBS AG | |
| 20.02.19 | Sartorius vz. Neutral | UBS AG | |
| 30.01.19 | Novartis Neutral | UBS AG | |
| 18.01.19 | Novartis Neutral | UBS AG | |
| 21.11.18 | Novartis Neutral | UBS AG | |
| 23.10.18 | Sartorius vz. Neutral | UBS AG | |
| 25.09.18 | Novartis Neutral | UBS AG | |
| 11.09.18 | Novartis Neutral | UBS AG | |
| 20.07.18 | Novartis Neutral | UBS AG | |
| 19.07.18 | Novartis Neutral | UBS AG | |
| 02.07.18 | Novartis Neutral | UBS AG | |
| 27.04.18 | Novartis Neutral | UBS AG | |
| 19.04.18 | Novartis Neutral | UBS AG | |
| 09.04.18 | Novartis Neutral | UBS AG | |
| 27.03.18 | Novartis Neutral | UBS AG | |
| 01.03.18 | Novartis Neutral | UBS AG | |
| 15.01.18 | Sanofi Neutral | UBS AG | |
| 15.01.18 | Roche Neutral | UBS AG | |
| 15.01.18 | Novartis Neutral | UBS AG | |
| 15.01.18 | AstraZeneca Neutral | UBS AG | |
| 30.10.17 | Novartis Neutral | UBS AG | |
| 26.10.17 | GSK Neutral | UBS AG | |
| 10.10.17 | GSK Neutral | UBS AG | |
| 28.08.17 | Novartis Neutral | UBS AG | |
| 01.08.17 | GSK Neutral | UBS AG | |
| 27.07.17 | GSK Neutral | UBS AG | |
| 26.07.17 | GSK Neutral | UBS AG | |
| 20.07.17 | Novartis Neutral | UBS AG | |
| 18.07.17 | Novartis Neutral | UBS AG | |
| 09.06.17 | GSK Neutral | UBS AG | |
| 24.05.17 | Novartis Neutral | UBS AG | |
| 15.05.17 | GSK Neutral | UBS AG | |
| 27.04.17 | GSK Neutral | UBS AG | |
| 21.04.17 | Novartis Neutral | UBS AG | |
| 06.04.17 | Novartis Neutral | UBS AG | |
| 14.03.17 | Novartis Neutral | UBS AG | |